Jason Gotlib
Division of Hematology
Stanford University Medical Center
Palo Alto
USA
Name/email consistency: high
- World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management. Gotlib, J. Am. J. Hematol. (2012)
- World health organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Gotlib, J. Am. J. Hematol. (2011)
- Eosinophilic myeloid disorders: new classification and novel therapeutic strategies. Gotlib, J. Curr. Opin. Hematol. (2010)
- A Phase II intra-patient dose-escalation trial of weight-based darbepoetin alfa with or without granulocyte-colony stimulating factor in myelodysplastic syndromes. Gotlib, J., Lavori, P., Quesada, S., Stein, R.S., Shahnia, S., Greenberg, P.L. Am. J. Hematol. (2009)
- On being metachromatic: mystique and misunderstanding in mastocytosis. Gotlib, J. Am. J. Hematol. (2009)
- Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias. Gotlib, J., Cools, J. Leukemia (2008)
- KIT mutations in mastocytosis and their potential as therapeutic targets. Gotlib, J. Immunol. Allergy. Clin. North. Am (2006)
- Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy. Gotlib, J., Cross, N.C., Gilliland, D.G. Best. Pract. Res. Clin. Haematol (2006)
- Farnesyltransferase inhibitor therapy in acute myelogenous leukemia. Gotlib, J. Curr. Hematol. Rep. (2005)
- Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Gotlib, J., Berubé, C., Growney, J.D., Chen, C.C., George, T.I., Williams, C., Kajiguchi, T., Ruan, J., Lilleberg, S.L., Durocher, J.A., Lichy, J.H., Wang, Y., Cohen, P.S., Arber, D.A., Heinrich, M.C., Neckers, L., Galli, S.J., Gilliland, D.G., Coutré, S.E. Blood (2005)
- Molecular classification and pathogenesis of eosinophilic disorders: 2005 update. Gotlib, J. Acta Haematol. (2005)
- The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Gotlib, J., Cools, J., Malone, J.M., Schrier, S.L., Gilliland, D.G., Coutré, S.E. Blood (2004)